Počet záznamů: 1  

Proteomics of anti-cancer drugs

  1. 1. 0328756 - UZFG-Y 2010 DE eng A - Abstrakt
    Kovářová, Hana - Martinková, Jiřina - Hrabáková, Rita - Skalníková, Helena - Novák, Petr - Hajdůch, M. - Gadher, S. J.
    Proteomics of anti-cancer drugs.
    [Proteomika protirakovinových drog.]
    FEBS Journal. Roč. 276, Supplement 1 (2009), s. 84-84 E-ISSN 1742-4658.
    [34th FEBS Congress. 04.07.2009-09.07.2009, Praha]
    Grant CEP: GA MŠk LC07017
    Výzkumný záměr: CEZ:AV0Z50450515; CEZ:AV0Z50200510
    Klíčová slova: proteomics * anti-cancer drugs * biomarkers
    Kód oboru RIV: FD - Onkologie a hematologie

    Clinical importance of biomarkers as a handle for monitoring therapeutics response is of growing importance. Our study is focused on monitoring molecular mechanisms of response to anti.cancer drugs at earlier time intervals to detect relevant proteins that are responsible fr primary changes in signalling networks that subsequently lead to irreversible anti-cancer processes.
    Trvalý link: http://hdl.handle.net/11104/0174987